EYPT:NASDAQ
EyePoint Inc
$12.34
arrow_downward
-1.52%(-0.19) 1D
$12.34
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 3, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$12.51
High
$12.51
Low
$12.17
Mkt. cap
1.03B
Avg. vol.
922.66K
Volume
830.60K
52-wk high
$19.01
52-wk low
$7.95
EPS
-$3.50
Beta
1.72
Shares outstanding
83.84M
No. of employees
214
Open
$12.51
High
$12.51
Low
$12.17
Mkt. cap
1.03B
Avg. vol.
922.66K
Volume
830.60K
52-wk high
$19.01
52-wk low
$7.95
EPS
-$3.50
Beta
1.72
Shares outstanding
83.84M
No. of employees
214
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to EYPT in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EYPT in the last 3 months.
Highest
Current $12.34
$68.00 (+451.05%)
Average
$36.40 (+194.98%)
Lowest
$20.00 (+62.07%)
News stories
From sources across the web
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio
AI content may include mistakes. Learn more